Cancer Moonshot Blue Ribbon Panel Report

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
The Blue Ribbon Panel report describes 10 transformative research recommendations for achieving the Cancer MoonshotSM's ambitious goal of making a decade's worth of progress in cancer prevention, diagnosis, and treatment in just 5 years.

Watch videos about the Blue Ribbon Panel recommendation topics

A. Establish a network for direct patient involvement

Engage patients to contribute their comprehensive tumor profile data to expand knowledge about what therapies work, in whom, and in which types of cancer.

B. Create a translational science network devoted exclusively to immunotherapy

Establish a cancer immunotherapy network to discover why immunotherapy is effective in some patients but not in others.

C. Develop ways to overcome cancer’s resistance to therapy

Identify therapeutic targets to overcome drug resistance through studies that determine the mechanisms that lead cancer cells to become resistant to previously effective treatments.

D. Build a national cancer data ecosystem

Create a national ecosystem for sharing and analyzing cancer data so that researchers, clinicians and patients will be able to contribute data, which will facilitate efficient data analysis.

E. Intensify research on the major drivers of childhood cancers

Improve our understanding of fusion oncoproteins in pediatric cancer and use new preclinical models to develop inhibitors that target them.

F. Minimize cancer treatment’s debilitating side effects

Accelerate the development of guidelines for routine monitoring and management of patient-reported symptoms to minimize debilitating side effects of cancer and its treatment.

G. Expand use of proven cancer prevention and early detection strategies

Reduce cancer risk and cancer health disparities through approaches in development, testing and broad adoption of proven prevention strategies.

H. Mine past patient data to predict future patient outcomes

Predict response to standard treatments through retrospective analysis of patient specimens.

I. Develop a 3-D cancer atlas

Create dynamic 3-D maps of human tumor evolution to document the genetic lesions and cellular interactions of each tumor as it evolves from a precancerous lesion to advanced cancer.

J. Develop new cancer technologies

Develop new enabling cancer technologies to characterize tumors and test therapies.

  • Updated: October 17, 2016

Most text on the National Cancer Institute website may be reproduced or reused freely. The National Cancer Institute should be credited as the source. Please note that blog posts that are written by individuals from outside the government may be owned by the writer, and graphics may be owned by their creator. In such cases, it is necessary to contact the writer, artist, or publisher to obtain permission for reuse.

We welcome your comments on this post. All comments must follow our comment policy.